Ronald Blasberg’s laboratory in the Molecular Pharmacology Program focuses on the development of preclinical, noninvasive, multimodality reporter-gene imaging and its translation into a clinical application. These approaches utilize modern molecular biology, cancer biology, and imaging (MRI, optical imaging, PET, and SPECT) techniques.
